Alterations of the p53 tumor suppressor gene are the most frequent gen
etic abnormalities in human malignancies, but the role of p53 in the e
tiology of malignant melanomas is unclear, Fifty unselected malignant
melanomas were analyzed for p53 overexpression by immunohistochemistry
using 3 monoclonal antibodies (MAbs), Fifteen tumors (29.4%) showed p
ositive staining with at least 2 different antibodies, In the first 20
consecutive tumors exons 5-9 and adjacent splice sites of the p53 gen
e were analyzed by genomic sequencing, There were 4 mutations in 20 me
tastatic melanomas, Three of 4 mutations were C:G --> T:A transitions,
A search of our database of p53 mutations revealed that out of 8 p53
mutations reported by others, 4 are C:G --> T:A transitions at dipyrim
idine sites, and one is a tandem CC --> TT mutation, This mutational p
attern is comparable with the pattern of p53 mutations in squamous cel
l and basal cell carcinomas of the skin and is related to exposure to
ultraviolet B (UV-B) wavelength radiation. Taken together with a predo
minance of UV-induced mutations in the CDKN2/p16 gene demonstrated in
melanoma cell lines, our data support a role of sunlight exposure in t
he etiology of malignant melanoma, The low frequency of p53 mutants in
melanomas compared with other types of skin cancers suggests that alt
hough mutations in this gene are likely to be involved in the developm
ent of some malignant melanomas, they do not play as large a role as i
n squamous and basal cell carcinomas of the skin. (C) 1996 Wiley-Liss,
Inc.